* Adapthealth Corp AHCO.OQ AHCO.O is expected to show a
rise
in quarterly revenue when it reports results on February 28.
* The Plymouth Meeting Pennsylvania-based company is
expected to
report a 12.2% increase in revenue to $788.09 million from
$702.11 million a year ago, according to the mean estimate from
10 analysts, based on Refinitiv data. The company's guidance on
November 8 2022, for the period ended December 31, was for
revenue between $760.00 million and $820.00 million.
* Refinitiv's mean analyst estimate for Adapthealth Corp is
for
earnings of 28 cents per share.
* The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 10 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Adapthealth
Corp
is $28, above its last closing price of $22.73.
The company's guidance on November 8 2022 for the period ended
December 31 was for Earnings before Interest, Taxes,
Depreciation and Amortization of between USD760 million and
USD202 million.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Sep. 30 2022 0.31 0.31 0.11 Missed -64.7
Jun. 30 2022 0.25 0.26 0.09 Missed -65
Mar. 31 2022 0.19 0.18 0.08 Missed -55.6
Dec. 31 2021 0.32 0.34 0.17 Missed -50.8
Sep. 0.27 0.28 0.20 Missed -28.6
30 2021
Jun. 30 2021 0.20 0.21 0.12 Missed -43.7
Mar. 31 2021 0.23 0.23 -0.04 Missed -117.1
Dec. 31 2020 0.16 0.17 -0.69 Missed -515.7
This summary was machine generated February 24 at 19:33 GMT.
All figures in US dollars unless otherwise stated